CAR-T Meeting 2020 | Academic vs. commercial CAR T-cell products

Arnon Nagler

Arnon Nagler, MD, Sheba Medical Center, Tel-Aviv, Israel, compares academic and commercial CAR T-cell products. Academic products give more flexibility to treat patients and have a lower cost, but from the regulatory perspective, commercial products may be preferable. Prof. Nagler believes there is room for both academic and commercial CAR T-cell products. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter